Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
91.05 USD | -0.12% | +0.10% | -4.22% |
Apr. 24 | Earnings Flash (AMED) AMEDISYS Reports Q1 EPS $1.03 | MT |
Apr. 24 | Amedisys, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Financials (USD)
Sales 2024 * | 2.34B | Sales 2025 * | 2.5B | Capitalization | 2.97B |
---|---|---|---|---|---|
Net income 2024 * | 144M | Net income 2025 * | 155M | EV / Sales 2024 * | 1.4 x |
Net Debt 2024 * | 305M | Net Debt 2025 * | 311M | EV / Sales 2025 * | 1.32 x |
P/E ratio 2024 * |
20.9
x | P/E ratio 2025 * |
19.5
x | Employees | 19,000 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 83.73% |
1 day | -0.12% | ||
1 week | +0.10% | ||
Current month | -1.20% | ||
1 month | -1.19% | ||
3 months | -4.11% | ||
6 months | -1.23% | ||
Current year | -4.22% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 49 | 23-04-09 | |
Scott Ginn
DFI | Director of Finance/CFO | 55 | 17-01-31 |
Paul Kusserow
CHM | Chairman | 62 | 14-12-15 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 70 | 15-04-21 | |
Molly Joel Coye
BRD | Director/Board Member | 76 | 19-10-31 |
Vickie Capps
BRD | Director/Board Member | 62 | 19-10-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
1.18% | 8 M€ | -.--% | ||
0.83% | 2 M€ | +5.19% | ||
0.24% | 509 M€ | -.--% | ||
0.17% | 45 M€ | +0.35% |
Date | Price | Change | Volume |
---|---|---|---|
24-04-24 | 91.05 | -0.12% | 81,673 |
24-04-23 | 91.16 | -0.09% | 102,925 |
24-04-22 | 91.24 | +0.93% | 159,364 |
24-04-19 | 90.4 | -0.42% | 384,904 |
24-04-18 | 90.78 | -0.20% | 223,250 |
Delayed Quote Nasdaq, April 24, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-4.22% | 2.97B | |
+2.85% | 1.53B | |
+48.78% | 622M | |
-1.74% | 510M | |
-37.03% | 367M | |
-14.54% | 138M | |
-37.76% | 132M | |
+3.85% | 68.94M |
- Stock Market
- Equities
- AMED Stock